Epidemiology of lung cancer prognosis: quantity and quality of life.
about
The Peter Brojde lung cancer centre: a model of integrative practice.Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests.Discovery of prognostic biomarkers for predicting lung cancer metastasis using microarray and survival data.Characterization of a transgenic mouse model exhibiting spontaneous lung adenocarcinomas with a metastatic phenotype.High expression of IRE1 in lung adenocarcinoma is associated with a lower rate of recurrenceTargeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cellsInhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance.Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC0Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerTumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancerElevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.A new strategy using ALDHhigh-CD8+T cells to inhibit tumorigenesis.Health-related quality of life in lung cancer survivors: Latent class and latent transition analysis.Cryosurgery for lung cancerOver-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer.Integrin and gene network analysis reveals that ITGA5 and ITGB1 are prognostic in non-small-cell lung cancermiR-223/FBW7 axis regulates doxorubicin sensitivity through epithelial mesenchymal transition in non-small cell lung cancer.Increased ZO-1 expression predicts valuable prognosis in non-small cell lung cancer.Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC).Optimal delivery of follow-up care following pulmonary lobectomy for lung cancer.The antitumor agent PBT-1 directly targets HSP90 and hnRNP A2/B1 and inhibits lung adenocarcinoma growth and metastasis.The EMT regulator slug and lung carcinogenesis.Cost analysis of adverse events associated with non-small cell lung cancer management in France.The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study.Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity.VER-155008, a small molecule inhibitor of HSP70 with potent anti-cancer activity on lung cancer cell lines.Genetically engineered humanized anti-ganglioside GM2 antibody against multiple organ metastasis produced by GM2-expressing small-cell lung cancer cells.Effects of silencing Rab27a gene on biological characteristics and chemosensitivity of non-small cell lung cancer.Screening of FOXD3 targets in lung cancer via bioinformatics analysis.Frequent loss of the expression of multiple subunits of the SWI/SNF complex in large cell carcinoma and pleomorphic carcinoma of the lung.Is traditional Chinese herbal medicine effective in prolonging survival times in extensive-stage small-cell lung cancer patients?Health-related quality of life in Chinese inpatients with lung cancer treatedin large general hospitals: across-sectional study.Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer PatientsAptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells
P2860
Q30417605-A61E65C6-0260-481F-8BA1-391B190F1216Q30827122-F5234246-5ECF-4598-8F0A-BE0A21218746Q30934284-2471B519-C045-4C9A-9A28-6DB3045FE6CFQ33574298-BC2651EE-1AB5-481B-8791-536E5C3F317DQ33737648-2D7DCFBC-AB4D-4213-8922-86720749113BQ33889144-02841DE1-11DC-491A-948B-670834567878Q33934763-FD6BF906-EBAE-43BE-BA47-E56BB3E185BCQ33995141-9049EAB4-546B-4268-ABB9-0BF95BE428A0Q34295621-1EC7E39D-AEB3-4ED4-8300-3953893E2FB6Q34657698-CE853F77-827E-427F-B7FE-7CA554F58968Q35079142-210F839C-4B66-4722-ADF1-576D04BA15EFQ35221936-9917DB28-6FCF-4EFE-8A49-A525446B7453Q35537225-D2D66B12-D066-4CC9-BE4F-7F35492D6B9FQ36186325-E722B210-4CD7-4EAC-9872-E6E03F7312BDQ36413067-D651DC5D-3AF7-492C-824A-CE9C32C15CBAQ36838793-93680E37-E883-408A-B800-69DB1497CD88Q37060753-F4906BC7-BAB0-4459-A5AF-CBD23AE729D4Q37349495-DA75A96E-59DE-458A-BD1D-11BCFCA0EF90Q37564704-712589DD-C193-4B17-BFCE-E9D0EB9125C1Q37643548-EABA60FC-24AF-4A51-9978-B233DB280F79Q37697405-AB62ED7F-D3C0-44BE-B808-9973C56A9E42Q37888326-D56ADF20-326F-4840-808A-2CA7A1AED01DQ38631475-094C38B1-B803-4B64-B147-0BB6BEA94427Q38796067-42463C9E-9A7A-41E9-86EB-A0C96EE286EDQ38943871-4F603429-0687-41E2-A81E-66EF6EDDA1AFQ39010794-9E387221-B40D-474A-AFB0-8D1B25EF9BA1Q39478999-E082CBDF-CAF2-4045-9A23-1ADD822D9ADCQ47105896-63230095-5429-4144-B468-E0D6DD3756B3Q49733370-94D89EB8-98FD-4976-AA13-BD43ACB54DD9Q52918952-71675D51-378E-49A9-951C-A091EE559836Q54057123-0B52CEF5-F96A-4715-8E33-44AFADC12E90Q55301778-1380BF82-5049-47ED-8C91-994DC7BA10CAQ56243510-093A5AF4-9D67-46EC-BB55-D7BBC3B4FAB5Q58549853-EBEA06DA-B5A2-4B13-9995-4EA675F722DD
P2860
Epidemiology of lung cancer prognosis: quantity and quality of life.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Epidemiology of lung cancer prognosis: quantity and quality of life.
@ast
Epidemiology of lung cancer prognosis: quantity and quality of life.
@en
Epidemiology of lung cancer prognosis: quantity and quality of life.
@nl
type
label
Epidemiology of lung cancer prognosis: quantity and quality of life.
@ast
Epidemiology of lung cancer prognosis: quantity and quality of life.
@en
Epidemiology of lung cancer prognosis: quantity and quality of life.
@nl
prefLabel
Epidemiology of lung cancer prognosis: quantity and quality of life.
@ast
Epidemiology of lung cancer prognosis: quantity and quality of life.
@en
Epidemiology of lung cancer prognosis: quantity and quality of life.
@nl
P2860
P1476
Epidemiology of lung cancer prognosis: quantity and quality of life.
@en
P2093
P2860
P304
P356
10.1007/978-1-59745-416-2_24
P407
P577
2009-01-01T00:00:00Z